Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Neumora Therapeutics's Navacaprant?
Navacaprant is a small molecule commercialized by Neumora Therapeutics, with a leading Phase III program in Major Depressive Disorder. According...
Data Insights
Risk adjusted net present value: What is the current valuation of Neumora Therapeutics's Navacaprant?
Navacaprant is a small molecule commercialized by Neumora Therapeutics, with a leading Phase III program in Major Depressive Disorder. According...